125P Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis
Castillo, J.J. Soto, de la Fuente, E. Corral, García, M.E. Olmedo, Rueda, A. Gómez, Lage, Y., Navas, E.M. Vida, Gómez, L. Sanz, Lario, M., Lopez, P. Garrido
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
1117P Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing
San Roman-Gil, M., Sanz-Gómez, L., Chamorro-Pérez, J., Lage, Y., Garcia, M.E.O., Gomez, A., Corral de la Fuente, E., Rosero-Rodríguez, D.I., Albarrán Fernández, V., Pozas, J., Alvarez-Ballesteros, P., Vida-Navas, E.M., Soto-Castillo, J.J., Torres-Jiménez, J., Esteban-Villarrubia, J., Orejana-Martín, I., Benito Berlinches, A., Garrido Lopez, P.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
218P Clinical characteristics and treatment outcomes in lung cancer patients with FGFR genes alterations
Jiménez, J. Torres, Villarrubia, J. Esteban, Navas, E.M. Vida, Castillo, J.J. Soto, Gómez, L. Sanz, Martín, I. Orejana, Ballesteros, P. Álvarez, Pérez, J. Pozas, Gil, M. San Román, Fernández, V. Albarrán, Pérez, J. Chamorro, Rodríguez, D.I. Rosero, Rueda, A. Gómez, de la Fuente, E. Corral, Lage, Y., Santón, A., Berlinches, A. Benito, Lario, M., García, M.E. Olmedo, Lopez, P. Garrido
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
52P Genetic and clinical profiling of a cohort of extended small cell lung carcinoma
Navas, E.M. Vida, Pérez, J. Chamorro, de la Fuente, E. Corral, Lage, Y., Rueda, A. Gómez, Jiménez, J. Torres, Gómez, L. Sanz, Castillo, J.J. Soto, Ballesteros, P. Álvarez, Villarrubia, J. Esteban, Fernández, V. Albarrán, Rodríguez, D.I. Rosero, Gil, M. San Román, Pérez, J. Pozas, Lario, M., Lizarralde, A. Caminoa, Lopez, P. Garrido, García, M.E. Olmedo
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
473P Predictive factors for drug-induced liver injury in patients with ER-positive HER2-negative metastatic breast cancer treated with first-line cyclin-dependent kinase 4/6 inhibitors
Cano, K.S. Vega, Javierre, G. Villacampa, Baselga, P. Mascaró, Mirallas, O., Adelantado, E. Zamora, Gomez, L. Sanz, Ortiz, C., Lapena, M. Cruellas, Arumi de Dios, M., Puy, M. Borrell, Filippi-Arriaga, F., Joval, L., Yaringaño, J.G., Martínez-Albaladejo, P., Buch, P.B., Esteban, P., Ruiz-Ortega, L., Manich, C. Saura, Riveiro-Barciela, M., Ezquerra, M. Bellet
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
Serrano Domingo, J.J., Corral de la Fuente, E., Martin Huertas, R., Vida Navas, E.M., Soto Castillo, J.J., Sanz Gomez, L., Torres Jimenez, J., Esteban Villarrubia, J., Orejana Martin, I., Alvarez Ballesteros, P., Pozas Perez, J., San Roman Gil, M.V., Garrido Lopez, P., Carrato Mena, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
38P Spatial analysis of the tumor microenvironment in hormone receptor-positive (HR+) young women breast cancer (YWBC) from a parity and lactation perspective
Sanso, M., Gomez, L. Sanz, Gorgal, T., Cordoba, O., Martinez, P., Fasani, R., Suñol, A., Gonzalez, F., Ortiz, C., Perello, A., Matheu, G., Jimenez, J., Nuciforo, P.G., Manich, C. Saura
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
27P Impact of chemotherapy (CT) use and stromal tumor-infiltrating lymphocytes (sTILs) in stage I triple-negative breast cancer (TNBC)
Barberi, V., Panet, F., Joval, L., Jaramillo, J.F. Chabla, Adelantado, E. Zamora, Pimentel, I., Puy, M. Borrell, Ezquerra, M. Bellet, Arumi de Dios, M.A., Gomez, L. Sanz, Calzado, E. Monescillo, Ortiz, C., Rezqallah Aron, M.A., Escrivá-De-Romaní, S., Lapena, M. Cruellas, Jimenez, J., Espinosa-Bravo, M., Cámara, V. Peg, Manich, C. Saura, Oliveira, M.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
29P Long-term performance of residual cancer burden (RCB): Clinical pathological stage (CPS) and CPS+ER+Grade (CPS-EG) models in ER+HER2- breast cancer (BC) patients (pts) after neoadjuvant chemotherapy (NAC) - Role of Ki67 drop and extended endocrine therapy (EET)
Gomez, L. Sanz, Adelantado, E. Zamora, Joval, L., Monescillo, E., Ortiz, C., Trabulo, C.F.P., Garcia, B. Rojas, Pascual, J., Puerto, D.A. Gomez, Salazar, S.A. Bueno, Rivero, J., Gómez, I. Miranda, Ariza, L. Rodriguez, Pardo, P. Gomez, Espinosa-Bravo, M., Manich, C. Saura, Javierre, G. Villacampa, Cámara, V. Peg, Dienstmann, R., Ezquerra, M. Bellet
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
62P KI67 in ER+HER2-negative pure invasive lobular breast carcinoma (ILC). What’s the best Ki67 threshold to differentiate prognosis?
Bellet-Ezquerra, M., Pardo, P. Gomez, Fasani, R., Villacampa, G., Portu, M., Serna, G., Joval, L., Petit, A., Ortega, A. Fernandez, Jimenez, J., Zamora, E., Gil, M.J., Gomez, L. Sanz, Viaplana, C., Gallego, F., Cámara, V. Peg, Manich, C. Saura, Simon, S. Pernas, Nuciforo, P.G.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
115P Longterm prognostic utility of 70-gene signature by clinical and genomic risks, including Ultralow (gUL) risk patients (pts)
Gomez, L. Sanz, Zamora, E., Joval, L., Velez, C. Ortiz, Puy, M. Borrell, Arumi de Dios, M.A., Puerto, D.A. Gomez, Garces, V. Navarro, Rezqallah Aron, M.A., Cano, K.S. Vega, Escrivá-De-Romaní, S., Mirallas, O., Pimentel, I., Lapena, M. Cruellas, Villacampa, G., Oliveira, M., Manich, C. Saura, Pardo, P. Gomez, Cámara, V. Peg, Bellet-Ezquerra, M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
63P Ki67 values and MammaPrint (MP) genomic risk in early breast cancer: Correlation by ductal vs lobular histology
Zamora, E., Gomez, L. Sanz, Joval, L., Ortiz Velez, C., Arumi de Dios, M.A., Puy, M. Borrell, Puerto, D.A. Gomez, Leao, I.I.L., Rezqallah Aron, M.A., Garces, V. Navarro, Villacampa, G., Manich, C. Saura, Pardo, P. Gomez, Cámara, V. Peg, Bellet-Ezquerra, M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
250P Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi)
Cano, K.S. Vega, Mascaro, P., Mirallas, O., Filippi-Arriaga, F., Joval, L., Zamora, E., Gomez, L. Sanz, Velez, C. Ortiz, Lapena, M. Cruellas, Arumi de Dios, M.A., Puy, M. Borrell, Esteban, P., Ruiz-Ortega, L., Buch, P.B., Yaringaño, J., Lores, G. Molina, Gomez-Puerto, D., Manich, C. Saura, Riveiro-Barciela, M., Bellet-Ezquerra, M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article